Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1320
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00148707 | Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer | ||
| NCT00146536 | Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy | ||
| NCT02251548 | A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia | ||
| NCT01024387 | AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors | ||
| NCT05629065 | Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) | ||
| NCT03333616 | Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors | ||
| NCT06488378 | Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer | ||
| NCT00372515 | High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations | ||
| NCT04802187 | Implementation of COVID-19 Testing Strategies in Community Health Centers | ||
| NCT00098514 | Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors | ||
| NCT01399658 | Image-Guided Gynecologic Brachytherapy | ||
| NCT02244463 | A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer | ||
| NCT04040725 | Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression | ||
| NCT02657343 | An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer. | ||
| NCT00165347 | Protein Tyrosine Kinases (PTK) in Multiple Myeloma | ||
| NCT03534323 | Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS | ||
| NCT02452710 | Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors | ||
| NCT06317220 | Vedolizumab for the Treatment of Collagenous Gastritis | ||
| NCT00116142 | Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer | ||
| NCT04094961 | Ixazomib + Pomalidomide + Dexamethasone In MM | ||
| NCT00458549 | Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery | ||
| NCT07569250 | Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization | ||
| NCT06692452 | Tazemetostat Plus CHOP in 1L T-cell Lymphoma | ||
| NCT03361852 | Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma | ||
| NCT07434843 | PH 2 Pemigatinib in SDH-deficient GIST | ||
| NCT04569747 | A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer | ||
| NCT07101458 | The Eswatini PRISM Study on Adolescents Living With HIV | ||
| NCT05643027 | A Novel Intervention for Patients With Cancer | ||
| NCT06844383 | A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide | ||
| NCT04339062 | Cemiplimab in AlloSCT/SOT Recipients With CSCC | ||
| NCT04653246 | Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM | ||
| NCT01253369 | Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer | ||
| NCT00630344 | RAD001 and Bicalutamide for Androgen Independent Prostate Cancer | ||
| NCT04724499 | Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy | ||
| NCT03417544 | Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC | ||
| NCT01796405 | Clofarabine for Langerhans in Pedi | ||
| NCT07624513 | D2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMM | ||
| NCT00165373 | rhEndostatin Protein Involving Pediatric Patients With Cancer | ||
| NCT00165503 | Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate | ||
| NCT00546156 | Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer | ||
| NCT01750762 | Lenalidomide After Allo Transplant | ||
| NCT06278896 | Early Neutropenic Fever De-escalation of Antibiotics Study | ||
| NCT00006127 | Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia | ||
| NCT04485767 | RESIST-ADT (Androgen Deprivation Therapy) | ||
| NCT07341867 | Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype | ||
| NCT00207636 | Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening | ||
| NCT01243619 | FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer | ||
| NCT04703426 | Sargramostim (GM-CSF) + PD-1 | ||
| NCT04685915 | Copanlisib Plus Ibrutinib or Acalabrutinib in R/R CLL | ||
| NCT00215059 | Measurement of Angiogenic Related Growth Factors in Urine and Blood From Patients With Pulmonary Vein Stenosis |
